Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Enlitic
AddedFeb 27, 2023
UpdatedJun 18, 2026
Enlitic

Enlitic

Series B

A pioneer in medical deep learning that leverages algorithms to improve healthcare diagnosis.

HQ
San Francisco, CA, US
Founded
2014
Overview
Analysis
Compare
Fundraising
Employees
Website

Enlitic, founded in 2014, is a pioneering company in the field of medical deep learning, dedicated to transforming healthcare through advanced AI technologies. Their core mission is to enhance the quality and efficiency of healthcare diagnosis by leveraging deep learning algorithms. Enlitic offers a suite of AI-driven workflow solutions that standardize, anonymize, and monetize medical imaging data, thereby addressing significant challenges at every stage of the clinical workflow. Their market focus includes healthcare systems worldwide, aiming to improve patient outcomes and operational efficiencies.

Notable figures associated with Enlitic include renowned AI experts and healthcare professionals who contribute to the company's innovative edge. The company has attracted significant investment from leading venture capital firms, underscoring its potential and credibility in the market. Key achievements include the development of an intelligent data framework that optimizes medical imaging processes and unlocks new revenue opportunities for healthcare providers. Enlitic's impact is evident in its ability to generate cost savings and enhance the comprehension of medical data, positioning it as a leader in the AI healthcare technology sector.

Enlitic - Similar Companies

4D Path logo

4D Path

4dpath.com

Proscia logo

Proscia

proscia.com

PathAI logo

PathAI

PathologyWatch logo

PathologyWatch

Paige logo

Paige

paige.ai

Viz.ai logo

Viz.ai

viz.ai

Artera logo

Artera

artera.io

Nucleai logo

Nucleai

DeepRadiology logo

DeepRadiology

deepradiology.com

Segmed logo

Segmed

segmed.ai

RAD AI logo

RAD AI

radai.com

Clairity logo

Clairity

Retina-Ai Health logo

Retina-Ai Health

Gradient Health logo

Gradient Health

gradienthealth.ai

Elucid Bioimaging logo

Elucid Bioimaging

Enlitic - Quick Facts

Who are Enlitic's competitors?

Companies similar to Enlitic include 4D Path, Proscia, PathAI and PathologyWatch.

When was Enlitic founded?

Enlitic was founded in 2014.

Where is Enlitic's headquarters located?

Enlitic's headquarters is located in San Francisco, CA, US.

When was Enlitic's last funding round?

Enlitic's most recent funding round was for $25M (USD) in November 2019.

How much has Enlitic raised to-date?

As of Nov 14, 2019, Enlitic has raised a total of $65M (USD).

How many employees does Enlitic have?

Enlitic has 64 employees as of Feb 4, 2024.

Enlitic - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostics
  • Healthcare
Tags
  • AI Operations
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software